|
Real-time Estimate
Tradegate
14:18:15 27/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 78.04 EUR | 0.00% |
|
0.00% | - |
| 10:48am | AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial | RE |
| 08-26 | Malin swings to interim profit as finance income rises and costs fall | AN |
| Market Cap | 93.8B 109B 88.04B 80.41B 152B 10,423B 152B 1,042B 404B 5,258B 410B 401B 17,416B | P/E 2026 * |
12.5x | P/E 2027 * | 10.9x |
|---|---|---|---|---|---|
| Enterprise Value | 105B 123B 98.79B 90.23B 170B 11,696B 171B 1,169B 453B 5,901B 460B 450B 19,544B | EV / Sales 2026 * |
2.21x | EV / Sales 2027 * | 2.01x |
| Free-Float |
88.34% | Yield 2026 * |
5.43% | Yield 2027 * | 5.75% |
Last Transcript : Sanofi
| 1 day | +2.25% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/05/2026 | |
| Director of Finance/CFO | 64 | 01/04/2024 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 11/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 30/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 57 | 28/04/2020 |
Lise Kingo
BRD | Director/Board Member | 65 | 28/04/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 109B | |
| -3.59% | -7.10% | +61.60% | +114.83% | 1,060B | |
| -1.15% | -1.25% | +52.98% | +62.41% | 651B | |
| -1.09% | -1.15% | +26.18% | +79.22% | 465B | |
| -0.41% | -1.61% | +39.30% | +41.15% | 365B | |
| -0.66% | -0.30% | +23.51% | +39.24% | 300B | |
| -0.06% | +1.29% | +2.81% | +12.98% | 258B | |
| -0.43% | -0.46% | +52.06% | +71.75% | 238B | |
| -2.02% | +0.35% | -16.68% | -54.03% | 210B | |
| -0.46% | +0.33% | +29.05% | +92.67% | 184B | |
| Average | -0.41% | -0.66% | +30.09% | +51.14% | 414.49B | |
| Weighted average by Cap. | -0.55% | -2.16% | +39.75% | +67.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.59B 55.45B 44.67B 40.8B 77B 5,289B 77.37B 529B 205B 2,668B 208B 204B 8,837B | 50.7B 59.07B 47.58B 43.46B 82.02B 5,634B 82.41B 563B 218B 2,842B 222B 217B 9,413B |
| Net income | 7.91B 9.22B 7.43B 6.78B 12.8B 879B 12.86B 87.87B 34.05B 444B 34.61B 33.86B 1,469B | 9.24B 10.77B 8.68B 7.92B 14.95B 1,027B 15.03B 103B 39.79B 518B 40.44B 39.56B 1,716B |
| Net Debt | 11.46B 13.35B 10.75B 9.82B 18.54B 1,273B 18.63B 127B 49.32B 642B 50.12B 49.03B 2,127B | 8.3B 9.67B 7.79B 7.12B 13.43B 923B 13.5B 92.24B 35.74B 466B 36.33B 35.54B 1,542B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
- 0O59 Stock
Select your edition
All financial news and data tailored to specific country editions
